Prostaglandin E₂ synthase inhibition as a therapeutic target

Author： Iyer Jitesh P Srivastava Punit K Dev Rishabh Dastidar Sunanda G Ray Abhijit

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.13, Iss.7, 2009-07, pp. : 849-865

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prostaglandin E Synthase: A Novel Drug Target for Inflammation and Cancer

Current Pharmaceutical Design, Vol. 12, Iss. 8, 2006-03 ,pp. : 943-954

Bentham Science Publishers

Access to resources Recommend Favorite

Microsomal Prostaglandin E Synthase: A Key Enzyme in PGE2 Biosynthesis and Inflammation

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 1, Iss. 3, 2002-12 ,pp. : 167-175

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Targets in Prostaglandin E2 Signaling for Neurologic Disease

Current Medicinal Chemistry, Vol. 15, Iss. 19, 2008-08 ,pp. : 1863-1869

Bentham Science Publishers

Access to resources Recommend Favorite

Prostaglandin E₂ is an enhancer of interleukin‐1β–induced expression of membrane‐associated prostaglandin E synthase in rheumatoid synovial fibroblasts

Arthritis & Rheumatism, Vol. 48, Iss. 10, 2003-10 ,pp. : 2819-2828

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inhibitors of the Microsomal Prostaglandin E2 Synthase-1 as Alternative to Non Steroidal Anti-Inflammatory Drugs (NSAIDs) - A Critical Review

Current Medicinal Chemistry, Vol. 16, Iss. 32, 2009-11 ,pp. : 4274-4296

Bentham Science Publishers

Access to resources Recommend Favorite